Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q40036974
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241221010713.0 |
008
|
|
|
241221nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q40036974
|
024
|
|
|
‡a
0000-0002-8860-7928
‡2
orcid
|
024
|
|
|
‡a
7203034838
‡2
scopus
|
035
|
|
|
‡a
(OCoLC)Q40036974
|
100
|
0 |
|
‡a
Laurent Perez
‡c
chercheur
‡9
fr
|
375
|
|
|
‡a
1
‡2
iso5218
|
400
|
0 |
|
‡a
Laurent Perez
‡c
researcher
‡9
en
|
400
|
0 |
|
‡a
Laurent Perez
‡c
onderzoeker
‡9
nl
|
400
|
0 |
|
‡a
Laurent Perez
‡c
investigador
‡9
ast
|
400
|
0 |
|
‡a
Laurent Perez
‡c
investigador
‡9
es
|
670
|
|
|
‡a
Author's A highly potent antibody effective against SARS-CoV-2 variants of concern
|
670
|
|
|
‡a
Author's A public antibody lineage that potently inhibits malaria infection through dual binding to the circumsporozoite protein.
|
670
|
|
|
‡a
Author's An Unbiased Screen for Human Cytomegalovirus Identifies Neuropilin-2 as a Central Viral Receptor
|
670
|
|
|
‡a
Author's AncesTree: An interactive immunoglobulin lineage tree visualizer
|
670
|
|
|
‡a
Author's Antibodies to combat viral infections: development strategies and progress
|
670
|
|
|
‡a
Author's Antibody-driven design of a human cytomegalovirus gHgLpUL128L subunit vaccine that selectively elicits potent neutralizing antibodies
|
670
|
|
|
‡a
Author's Cadmium induces direct morphological changes in mesangial cell culture
|
670
|
|
|
‡a
Author's Characterization of a new family of cyclin-dependent kinase activators
|
670
|
|
|
‡a
Author's Clonal analysis of immunodominance and cross-reactivity of the CD4 T cell response to SARS-CoV-2
|
670
|
|
|
‡a
Author's Cross-neutralization of four paramyxoviruses by a human monoclonal antibody
|
670
|
|
|
‡a
Author's Differential regulation of Cdc2 and Cdk2 by RINGO and cyclins
|
670
|
|
|
‡a
Author's Direct bacterial killing in vitro by recombinant Nod2 is compromised by Crohn's disease-associated mutations
|
670
|
|
|
‡a
Author's False human cytomegalovirus IgG-positivity at prenatal screening
|
670
|
|
|
‡a
Author's HCMV Envelope Glycoprotein Diversity Demystified
|
670
|
|
|
‡a
Author's Hitting the right spot: Mechanism of action of OPB-31121, a novel and potent inhibitor of the Signal Transducer and Activator of Transcription 3 (STAT3)
|
670
|
|
|
‡a
Author's Human cytomegalovirus (HCMV)-specific T cell but not neutralizing or IgG binding antibody responses to glycoprotein complexes gB, gHgLgO, and pUL128L correlate with protection against high HCMV viral load reactivation in solid-organ transplant recipi
|
670
|
|
|
‡a
Author's Mitochondrial dysfunction induced by a SH2 domain-targeting STAT3 inhibitor leads to metabolic synthetic lethality in cancer cells
|
670
|
|
|
‡a
Author's Monoclonal Antibodies to Different Components of the Human Cytomegalovirus
|
670
|
|
|
‡a
Author's Monoclonal Antibodies to Different Components of the Human Cytomegalovirus (HCMV) Pentamer gH/gL/pUL128L and Trimer gH/gL/gO as well as Antibodies Elicited during Primary HCMV Infection Prevent Epithelial Cell Syncytium Formation.
|
670
|
|
|
‡a
Author's Negative regulation of cell-cycle progression by RINGO/Speedy E.
|
670
|
|
|
‡a
Author's Platelet-derived growth factor-α receptor is the cellular receptor for human cytomegalovirus gHgLgO trimer
|
670
|
|
|
‡a
Author's Protection against influenza infection requires early recognition by inflammatory dendritic cells through C-type lectin receptor SIGN-R1
|
670
|
|
|
‡a
Author's Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody
|
670
|
|
|
‡a
Author's Quantitative SUMO-1 modification of a vaccinia virus protein is required for its specific localization and prevents its self-association
|
670
|
|
|
‡a
Author's Rationally designed Human Cytomegalovirus gB nanoparticle vaccine with improved immunogenicity
|
670
|
|
|
‡a
Author's Structural basis for HCMV Pentamer receptor recognition and antibody neutralization
|
670
|
|
|
‡a
Author's The C-terminal domain of TPX2 is made of alpha-helical tandem repeats
|
670
|
|
|
‡a
Author's The CD28-Transmembrane Domain Mediates Chimeric Antigen Receptor Heterodimerization With CD28
|
670
|
|
|
‡a
Author's The plant TPX2 protein regulates prospindle assembly before nuclear envelope breakdown
|
670
|
|
|
‡a
Author's Virus-Like Particles and Nanoparticles for Vaccine Development against HCMV
|
670
|
|
|
‡a
Author's Xkid chromokinesin is required for the meiosis I to meiosis II transition in Xenopus laevis oocytes
|
909
|
|
|
‡a
(scopus) 7203034838
‡9
1
|
909
|
|
|
‡a
(orcid) 0000000288607928
‡9
1
|
919
|
|
|
‡a
crossneutralizationof4paramyxovirusesbyahumanmonoclonalantibody
‡A
Cross-neutralization of four paramyxoviruses by a human monoclonal antibody
‡9
1
|
919
|
|
|
‡a
clonalanalysisofimmunodominanceandcrossreactivityofthecd4tcellresponsetosarscov2
‡A
Clonal analysis of immunodominance and cross-reactivity of the CD4 T cell response to SARS-CoV-2
‡9
1
|
919
|
|
|
‡a
unbiasedscreenforhumancytomegalovirusidentifiesneuropilin2asacentralviralreceptor
‡A
An Unbiased Screen for Human Cytomegalovirus Identifies Neuropilin-2 as a Central Viral Receptor
‡9
1
|
919
|
|
|
‡a
hcmvenvelopeglycoproteindiversitydemystified
‡A
HCMV Envelope Glycoprotein Diversity Demystified
‡9
1
|
919
|
|
|
‡a
monoclonalantibodiestodifferentcomponentsofthehumancytomegalovirushcmvpentamerghglpul128landtrimerghgl5aswellasantibodieselicitedduringprimaryhcmvinfectionpreventepithelialcellsyncytiumformation
‡A
Monoclonal Antibodies to Different Components of the Human Cytomegalovirus (HCMV) Pentamer gH/gL/pUL128L and Trimer gH/gL/gO as well as Antibodies Elicited during Primary HCMV Infection Prevent Epithelial Cell Syncytium Formation.
‡9
1
|
919
|
|
|
‡a
publicantibodylineagethatpotentlyinhibitsmalariainfectionthroughdualbindingtothecircumsporozoiteprotein
‡A
A public antibody lineage that potently inhibits malaria infection through dual binding to the circumsporozoite protein.
‡9
1
|
919
|
|
|
‡a
antibodydrivendesignofahumancytomegalovirusghglpul128lsubunitvaccinethatselectivelyelicitspotentneutralizingantibodies
‡A
Antibody-driven design of a human cytomegalovirus gHgLpUL128L subunit vaccine that selectively elicits potent neutralizing antibodies
‡9
1
|
919
|
|
|
‡a
humancytomegalovirushcmvspecifictcellbutnotneutralizingoriggbindingantibodyresponsestoglycoproteincomplexesgbghglgoandpul128lcorrelatewithprotectionagainsthighhcmvviralloadreactivationinsolidorgantransplantrecipi
‡A
Human cytomegalovirus (HCMV)-specific T cell but not neutralizing or IgG binding antibody responses to glycoprotein complexes gB, gHgLgO, and pUL128L correlate with protection against high HCMV viral load reactivation in solid-organ transplant recipi
‡9
1
|
919
|
|
|
‡a
highlypotentantibodyeffectiveagainstsarscov2variantsofconcern
‡A
A highly potent antibody effective against SARS-CoV-2 variants of concern
‡9
1
|
919
|
|
|
‡a
cadmiuminducesdirectmorphologicalchangesinmesangialcellculture
‡A
Cadmium induces direct morphological changes in mesangial cell culture
‡9
1
|
919
|
|
|
‡a
characterizationofanewfamilyofcyclindependentkinaseactivators
‡A
Characterization of a new family of cyclin-dependent kinase activators
‡9
1
|
919
|
|
|
‡a
directbacterialkillinginvitrobyrecombinantnod2iscompromisedbycrohnsdiseaseassociatedmutations
‡A
Direct bacterial killing in vitro by recombinant Nod2 is compromised by Crohn's disease-associated mutations
‡9
1
|
919
|
|
|
‡a
monoclonalantibodiestodifferentcomponentsofthehumancytomegalovirus
‡A
Monoclonal Antibodies to Different Components of the Human Cytomegalovirus
‡9
1
|
919
|
|
|
‡a
plateletderivedgrowthfactorαreceptoristhecellularreceptorforhumancytomegalovirusghglgotrimer
‡A
Platelet-derived growth factor-α receptor is the cellular receptor for human cytomegalovirus gHgLgO trimer
‡9
1
|
919
|
|
|
‡a
protectionagainstinfluenzainfectionrequiresearlyrecognitionbyinflammatorydendriticcellsthrough100typelectinreceptorsignr1
‡A
Protection against influenza infection requires early recognition by inflammatory dendritic cells through C-type lectin receptor SIGN-R1
‡9
1
|
919
|
|
|
‡a
protectivemonotherapyagainstlethalebolavirusinfectionbyapotentlyneutralizingantibody
‡A
Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody
‡9
1
|
919
|
|
|
‡a
quantitativesumo1modificationofavacciniavirusproteinisrequiredforitsspecificlocalizationandpreventsitsselfassociation
‡A
Quantitative SUMO-1 modification of a vaccinia virus protein is required for its specific localization and prevents its self-association
‡9
1
|
919
|
|
|
‡a
rationallydesignedhumancytomegalovirusgbnanoparticlevaccinewithimprovedimmunogenicity
‡A
Rationally designed Human Cytomegalovirus gB nanoparticle vaccine with improved immunogenicity
‡9
1
|
919
|
|
|
‡a
structuralbasisforhcmvpentamerreceptorrecognitionandantibodyneutralization
‡A
Structural basis for HCMV Pentamer receptor recognition and antibody neutralization
‡9
1
|
919
|
|
|
‡a
100terminaldomainoftpx2ismadeofalphahelicaltandemrepeats
‡A
The C-terminal domain of TPX2 is made of alpha-helical tandem repeats
‡9
1
|
919
|
|
|
‡a
cd28transmembranedomainmediateschimericantigenreceptorheterodimerizationwithcd28
‡A
The CD28-Transmembrane Domain Mediates Chimeric Antigen Receptor Heterodimerization With CD28
‡9
1
|
919
|
|
|
‡a
planttpx2proteinregulatesprospindleassemblybeforenuclearenvelopebreakdown
‡A
The plant TPX2 protein regulates prospindle assembly before nuclear envelope breakdown
‡9
1
|
919
|
|
|
‡a
viruslikeparticlesandnanoparticlesforvaccinedevelopmentagainsthcmv
‡A
Virus-Like Particles and Nanoparticles for Vaccine Development against HCMV
‡9
1
|
919
|
|
|
‡a
xkidchromokinesinisrequiredforthemeiosis1tomeiosis2transitioninxenopuslaevisoocytes
‡A
Xkid chromokinesin is required for the meiosis I to meiosis II transition in Xenopus laevis oocytes
‡9
1
|
919
|
|
|
‡a
differentialregulationofcdc2andcdk2byringoandcyclins
‡A
Differential regulation of Cdc2 and Cdk2 by RINGO and cyclins
‡9
1
|
919
|
|
|
‡a
hittingtherightspotmechanismofactionofopb31121anovelandpotentinhibitorofthesignaltransducerandactivatoroftranscription3stat3
‡A
Hitting the right spot: Mechanism of action of OPB-31121, a novel and potent inhibitor of the Signal Transducer and Activator of Transcription 3 (STAT3)
‡9
1
|
919
|
|
|
‡a
falsehumancytomegalovirusiggpositivityatprenatalscreening
‡A
False human cytomegalovirus IgG-positivity at prenatal screening
‡9
1
|
919
|
|
|
‡a
antibodiestocombatviralinfectionsdevelopmentstrategiesandprogress
‡A
Antibodies to combat viral infections: development strategies and progress
‡9
1
|
919
|
|
|
‡a
mitochondrialdysfunctioninducedbyash2domaintargetingstat3inhibitorleadstometabolicsyntheticlethalityincancercells
‡A
Mitochondrial dysfunction induced by a SH2 domain-targeting STAT3 inhibitor leads to metabolic synthetic lethality in cancer cells
‡9
1
|
919
|
|
|
‡a
negativeregulationofcellcycleprogressionbyringospeedye
‡A
Negative regulation of cell-cycle progression by RINGO/Speedy E.
‡9
1
|
919
|
|
|
‡a
ancestreeaninteractiveimmunoglobulinlineagetreevisualizer
‡A
AncesTree: An interactive immunoglobulin lineage tree visualizer
‡9
1
|
946
|
|
|
‡a
b
‡9
1
|
996
|
|
|
‡2
LC|n 80005274
|
996
|
|
|
‡2
ISNI|0000000060958393
|
996
|
|
|
‡2
BNC|981061035242206706
|
996
|
|
|
‡2
BNE|XX1680782
|
996
|
|
|
‡2
JPG|500063479
|
996
|
|
|
‡2
ICCU|CUBV122908
|
996
|
|
|
‡2
BNE|XX1140568
|
996
|
|
|
‡2
RERO|A022495988
|
996
|
|
|
‡2
J9U|987007389454305171
|
996
|
|
|
‡2
ISNI|0000000369696176
|
996
|
|
|
‡2
BNE|XX1395094
|
996
|
|
|
‡2
RERO|A025017269
|
996
|
|
|
‡2
BNF|15121091
|
996
|
|
|
‡2
LC|ns2011001588
|
996
|
|
|
‡2
SUDOC|083338020
|
996
|
|
|
‡2
BNC|981058516162306706
|
996
|
|
|
‡2
DNB|130284858
|
996
|
|
|
‡2
SUDOC|27040869X
|
996
|
|
|
‡2
DNB|1301145300
|
996
|
|
|
‡2
RERO|A024508317
|
996
|
|
|
‡2
SUDOC|068627181
|
996
|
|
|
‡2
BNE|XX1644367
|
996
|
|
|
‡2
BNE|XX850589
|
996
|
|
|
‡2
ISNI|0000000032029562
|
996
|
|
|
‡2
BNE|XX1062053
|
996
|
|
|
‡2
DNB|1122069278
|
996
|
|
|
‡2
NTA|131087118
|
996
|
|
|
‡2
NII|DA11326779
|
996
|
|
|
‡2
BNE|XX936416
|
996
|
|
|
‡2
BNE|XX4890473
|
996
|
|
|
‡2
DNB|130379034
|
996
|
|
|
‡2
RERO|A025685050
|
996
|
|
|
‡2
BNF|14127500
|
996
|
|
|
‡2
BNE|XX1106357
|
996
|
|
|
‡2
SUDOC|079281419
|
996
|
|
|
‡2
SUDOC|128257040
|
996
|
|
|
‡2
NTA|150648456
|
996
|
|
|
‡2
BNE|XX1375206
|
996
|
|
|
‡2
DNB|1157357857
|
996
|
|
|
‡2
NII|DA05328554
|
996
|
|
|
‡2
SUDOC|20062069X
|
996
|
|
|
‡2
LC|n 2018060627
|
996
|
|
|
‡2
BNE|XX5684926
|
996
|
|
|
‡2
SUDOC|150560079
|
996
|
|
|
‡2
LC|no2011018520
|
996
|
|
|
‡2
LC|n 96007564
|
996
|
|
|
‡2
LC|n 2024037780
|
996
|
|
|
‡2
RERO|A016281355
|
996
|
|
|
‡2
CAOONL|ncf13781780
|
996
|
|
|
‡2
SUDOC|259809934
|
996
|
|
|
‡2
ISNI|0000000115055889
|
996
|
|
|
‡2
SUDOC|170622967
|
996
|
|
|
‡2
BNE|XX829855
|
996
|
|
|
‡2
NDL|00524959
|
996
|
|
|
‡2
LIH|LNB:_p__j_F;=B_w_
|
996
|
|
|
‡2
LC|n 90605086
|
996
|
|
|
‡2
DNB|1202376142
|
996
|
|
|
‡2
ISNI|0000000031364983
|
996
|
|
|
‡2
BNE|XX6406872
|
996
|
|
|
‡2
BNF|17157353
|
996
|
|
|
‡2
LC|no2024111331
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|